Veranova Appoints Matteo Villain as VP of Peptides and Oligonucleotides
Veranova appoints Matteo Villain as Vice President of Peptides and Oligonucleotides, strengthening its position as a key player in the Peptide and Oligonucleotide (TIDES) space.
Veranova
Veranova Appoints Scott Zugel as New Global VP
Veranova welcomes Scott Zugel as Global VP of Analytical Research Development Operations.
The Evolution of the CDMO Industry
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine. CHEManager asked executives and industry experts from a broad range of CDMOs to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Expert Statement: Rohtash Kumar, Veranova
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Veranova Appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer
Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutical and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer.
Veranova Expands ADC and HPAPI Capabilities in the US
US contract development and manufacturing organization (CDMO) Veranova has initiated an expansion of its antibody-drug conjugate (ADC) and highly potent active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities at its US facility in Devens, Massachusetts.
Veranova Appoints Chris Holmes as Vice President, Global Engineering
Veranova has appointed Chris Holmes as the company’s first vice president, Global Engineering. He will lead Veranova’s global engineering team in the planning, design, and execution of the company’s capital investment initiatives and lead strategic capital projects.
Lucas Sauer-Jones Appointed as Vice President & General Manager of Veranova’s New England Sites
US API maker Veranova has appointed Lucas Sauer-Jones as the company’s vice president & general manager, New England. He will be responsible for Veranova’s sites in Devens and North Andover.
Veranova Appoints William Sanders as Global VP of Chemical Development Operations
US contract development and manufacturing organization (CDMO) Veranova has appointed William Sanders as global vice president of chemical development operations, effective Sep. 18, 2023.
Victoria Brown Joins as SVP, Chief HR Officer at Veranova
Veranova announced the appointment of Victoria Brown as the company’s SVP, Chief Human Resources Officer (CHRO) based in Devens, MA, US.
Veranova Completes API Expansion at Edinburgh
Macfarlan Smith, a UK-based unit of US API maker Veranova, formerly known as Johnson Matthey Health, has completed a $10 million expansion of its mid-scale active pharmaceutical ingredient (API) manufacturing capabilities in Edinburgh, Scotland.
Flow Chemistry
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Flow Chemistry
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Expert Statement: Shawn Walker, Veranova
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
